"The U.S. Food and Drug Administration yesterday approved Obizur [Antihemophilic Factor (Recombinant), Porcine Sequence] for the treatment of bleeding episodes in adults with acquired hemophilia A (acquired Factor VIII [FVII] deficiency).
Because this product is not used directly by patients, patient counseling or instructions for use by patients is not considered necessary.
Last reviewed on RxList: 2/1/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Voluven Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.